Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human TrkA Protein (Fc Tag) (AC1058)
Cat.#: ACPP-1058
Specifications
Despition Recombinant Human TrkA Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence NTRK1 (Ala33-Phe410) + hFc (Glu99-Ala330) Molecular Weight 67.4 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1049 Recombinant Human Galectin 3 Protein (6×His Tag) (AC1049) 50 µg inquiry ACPP-1011 Recombinant Human FGF1 Protein (AC1011) 50 µg inquiry ACPP-1401 Rat Midkine Protein (AC1401) 5 µg inquiry ACPP-1015 Recombinant Human ROR1 Protein (Fc Tag) (AC1015) 50 µg inquiry ACPP-1298 Syndecan-1 Blocking Peptide (AC1298) 250 µg inquiry ACPP-1323 FYN Blocking Peptide (AC1323) 250 µg inquiry ACPP-1073 Dopamine D5 Receptor Blocking Peptide (AC1073) 250 µg inquiry ACPP-1032 Recombinant Human PGRPS Protein (6×His Tag) (AC1032) 50 µg inquiry ACPP-1645 Human FAM84B Protein (AC1645) 5 µg inquiry ACPP-1012 Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket